Browse the latest news, stories and project updates from Doctors Without Borders.

    Transparency milestone: Doctors Without Borders reveals cost of its landmark TB clinical trial
    Transparency milestone: Doctors Without Borders reveals cost of its landmark TB clinical trial
    Doctors Without Borders urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all.
    Access to medicines
    Tuberculosis (TB)
    Infectious diseases
    Tuberculosis: Doctors Without Borders launches unprecedented project to tackle underdiagnosis among children
    India
    Tuberculosis: Doctors Without Borders launches unprecedented project to tackle underdiagnosis among children
    Tuberculosis (TB) in children is a silent scourge: one child dies of tuberculosis every three minutes and more than half of all children with TB are n...
    Tuberculosis (TB)
    Access to medicines
    Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    India
    Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis
    Tuberculosis (TB)
    Doctors Without Borders warns governments are failing to test, treat and prevent TB in children
    Doctors Without Borders warns governments are failing to test, treat and prevent TB in children
    Governments must immediately implement latest WHO guidelines to stop children dying from this deadly yet curabledisease.
    Tuberculosis (TB)
    Access to medicines
    Myanmar: Global progress tackling Tuberculosis can benefit patients if healthcare is urgently depoliticised
    Myanmar
    Myanmar: Global progress tackling Tuberculosis can benefit patients if healthcare is urgently depoliticised
    We speak to Dr Mark Sherlock, Doctors Without Borders / Médecins Sans Frontières (MSF) Health Programme Manager for Myanmar. Dr Sherlock explains the ...
    Tuberculosis (TB)
    Access to medicines
    US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
    US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
    12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Natio...
    Access to medicines
    Tuberculosis (TB)
    Cyclone Mocha: Aid efforts severely hampered by new restrictions
    Myanmar
    Cyclone Mocha: Aid efforts severely hampered by new restrictions
    “About 85 per cent of my camp is in ruins after Cyclone Mocha wreaked havoc here. All hut-like houses are destroyed. People who live in houses like th...
    Natural disasters
    Refugees
    Tuberculosis (TB)
    HIV/AIDS
    Hepatitis C
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    India
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    Recent deal offering controlled generics access in limited countries does not go far enough.
    Tuberculosis (TB)
    Access to medicines
    An introduction to Digital Therapeutics (DTx) in global health and humanitarian settings
    Sweden
    An introduction to Digital Therapeutics (DTx) in global health and humanitarian settings
    Doctors Without Borders / Médecins Sans Frontières (MSF) is committed to becoming increasingly person-centred, working with people as partners and sup...
    Tuberculosis (TB)
    Stay up to date
    © Doctors Without Borders
    Privacy Policy